The oncogenic roles of RTN4/Nogo have been investigated in various cancers, including oligodendroglioma [44]; non-small-cell lung cancer [45]; hepatocellular [46], cervical [47], colorectal [48], and nasopharyngeal carcinoma [49]; as well as BC [50,51,52]. This evidence concerns the gene RTN4 and oligodendroglioma.